Staley Capital Advisers Inc Myriad Genetics Inc Transaction History
Staley Capital Advisers Inc
- $2.2 Billion
- Q4 2024
Shares
2 transactions
Others Institutions Holding MYGN
# of Institutions
230Shares Held
88.9MCall Options Held
43.5KPut Options Held
18.1K-
Black Rock Inc. New York, NY15.2MShares$221 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.6MShares$154 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA6MShares$87.4 Million0.02% of portfolio
-
State Street Corp Boston, MA5.53MShares$80.5 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.35MShares$63.3 Million0.03% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $1.17B
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...